Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03461705 · ClinicalTrials.gov registry record · NA
Novel Adenosine-independent Index of Coronary Artery Stenosis Severity Resting Flow Reserve
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03461705 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 5 participants.
The verdict
NCT03461705, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will enroll patients who are referred for coronary angiography and require physiological assessment to see if the lesion can be treated as per the local standard of care. Approximately 92 participants will be enrolled. There are no follow up visits required so participation in this study will end when subjects are discharged from the hospital.The study will be comparing the resting flow reserve against the instantaneous wave-free ratio (iFR) and fractional flow reserve. All these tests offer a way to image a legion and determine if it is suitable to be treated. FFR measures the pressure differences across (narrowed coronary arteries usually due to atherosclerosis), iFR's are performed during cardiac catheterisation (angiography) using invasive coronary pressure wires which are placed in the arteries of the heart that are to be assessed and the Resting flow reserve looks at the maximum increase in blood flow through the coronary arteries above the normal resting volume.
Interventions
- DEVICE Volcano Verrata Pressure Wire
- DEVICE St. Jude Medical (SJM) Aeris Pressure Wire System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-10-20 |
| Est. Completion | 2018-08-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03461705
The ClinicalTrials.gov registry entry for NCT03461705 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Volcano Verrata Pressure Wire is the first listed.
NCT03461705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03461705 about?
NCT03461705 is a clinical study titled "Novel Adenosine-independent Index of Coronary Artery Stenosis Severity Resting Flow Reserve". This study will enroll patients who are referred for coronary angiography and require physiological assessment to see if the lesion can be treated as per the local standard of care. Approximately 92 participants will be enrolled. There are no follow up visits required so participation in this study ...
What is the current status of trial NCT03461705?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2017-10-20. Estimated completion is 2018-08-02.
What interventions are being tested in trial NCT03461705?
The interventions under investigation include: Volcano Verrata Pressure Wire (DEVICE), St. Jude Medical (SJM) Aeris Pressure Wire System (DEVICE).
Who is sponsoring clinical trial NCT03461705?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.